Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C

This article discusses the clinical value of Pegylated Interferon (PEG-IFN) α-2a combined with entecavir or tenofovir in the treatment of Chronic Hepatitis B (CHB) genotype C patients. 78 patients with CHB genotype C were divided into three groups: control group, entecavir group, and tenofovir group...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jiao, Xu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534658/
https://www.ncbi.nlm.nih.gov/pubmed/36247853
http://dx.doi.org/10.1155/2022/7623832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534658/
https://www.ncbi.nlm.nih.gov/pubmed/36247853
http://dx.doi.org/10.1155/2022/7623832

Ejemplares similares